Trending News

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

BREAKING: District Court Restores Status Quo Ante At NLRB

Update: Federal Judge Reinstates National Labor Relations Board (NLRB) Member (US)

Virginia Poised to Become Second State to Enact Comprehensive AI Legislation

Michigan Federal Court Holds CTA Reporting Rule Unconstitutional, Enjoins Enforcement Against Named Plaintiffs

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers
Posted On Thursday, March 27, 2025
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
Posted On Thursday, March 27, 2025
Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements
Posted On Thursday, March 27, 2025
Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
Posted On Thursday, March 27, 2025
AIM ImmunoTech Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Posted On Thursday, March 27, 2025
SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer
Posted On Thursday, March 27, 2025
Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results
Posted On Thursday, March 27, 2025
BioVie to Host KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and its ADDRESS-LC Trial on April 10, 2025
Posted On Thursday, March 27, 2025
Arcutis to Present at the 24th Annual Needham Virtual Healthcare Conference
Posted On Thursday, March 27, 2025
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
Posted On Thursday, March 27, 2025
4DMT to Participate in Upcoming Investor Conferences
Posted On Thursday, March 27, 2025
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, March 27, 2025
New Data to Be Presented at Upcoming Congresses Showcase Cerevance's Advanced Clinical Program in Parkinson’s Disease and Deep Pipeline for CNS-based Disorders
Posted On Thursday, March 27, 2025
Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update
Posted On Thursday, March 27, 2025
PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
Posted On Thursday, March 27, 2025
BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference
Posted On Thursday, March 27, 2025
Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors
Posted On Thursday, March 27, 2025
Soleno Therapeutics Announces U.S. FDA Approval of VYKAT(TM) XR to Treat Hyperphagia in Prader-Willi Syndrome
Posted On Wednesday, March 26, 2025
BioCardia Reports 2024 Business Highlights and Financial Results
Posted On Wednesday, March 26, 2025
Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors
Posted On Wednesday, March 26, 2025
Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment
Posted On Wednesday, March 26, 2025
Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102
Posted On Wednesday, March 26, 2025
Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates
Posted On Wednesday, March 26, 2025
Dyadic Reports 2024 Year-End Financial Results and Business Updates
Posted On Wednesday, March 26, 2025
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025
Posted On Wednesday, March 26, 2025

First page
Previous page
…
4
5
6
7
8
9
10
11
12
…
Next page
Last page

Print